<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00638560</url>
  </required_header>
  <id_info>
    <org_study_id>MB-MR-2008-290208</org_study_id>
    <nct_id>NCT00638560</nct_id>
  </id_info>
  <brief_title>Changes of Biomarkers in Response to Training and Antioxidant Treatment</brief_title>
  <official_title>Effects of Training and Antioxidant Treatment on Circulating Markers of Oxidative Stress and Skeletal Muscle mRNA Expression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Jena</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the effects of an intensive 4 weeks exercise training
      program with or without additional treatment with antioxidants. 16 volunteers are included
      into the study and randomized into a treatment (n=8,Vitamine E 400 IU od + vitamine C 1g
      twice daily) and a non-treatment (n=8, training only) group. Before and after the training
      program, skeletal muscle biopsies will be taken to measure PGC-1alpha and PPARgamma mRNA
      expression. In addition before and after the training program individuals will have the
      following measurements: body weight, waist circumference, body fat content (DEXA scan),
      euglycemic-hyperinsulinemic clamps, ergospirometer (VO2 max), routine laboratory
      measurements, serum malondialdehyde concentrations.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PGC-1alpha mRNA expression in skeletal muscle PPARgamma mRNA expression in skeletal muscle Serum malondialdehyde concentration</measure>
    <time_frame>after 4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>body weight glucose infusion rate during the steady state of an euglycemic-hyperinsulinemic clamp VO2max</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Obesity</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Antioxidant treatment arm:
Vitamin E, 400 IU po, once daily Vitamin C, 1g po, twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin C, Vitamin E</intervention_name>
    <description>Vitamin C, 1g po, twice daily Vitamin E, 400 IU po, once daily</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Antioxidant treatment</intervention_name>
    <description>no treatment</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be able to swallow tablets

          -  signed informed consent

          -  no concommitant medication

          -  male

          -  age between 25 - 35 years

        Exclusion Criteria:

          -  drug, tobacco or alcohol abuse

          -  any chronic disease

          -  any acute or chronic inflammatory disease as determined by a leucocyte count &gt; 7000
             Gpt/l, C-reactive protein (CrP) &gt; 5.0 mg/dl or clinical signs of infection

          -  systolic blood pressure (SBP) &gt; 140mmHg and diastolic blood pressure (DBP) was &gt;
             85mmHg

          -  cardiovascular or peripheral artery disease

          -  thyroid dysfunction
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Blüher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leipzig</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2008</study_first_submitted>
  <study_first_submitted_qc>March 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2008</study_first_posted>
  <last_update_submitted>January 19, 2010</last_update_submitted>
  <last_update_submitted_qc>January 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. med. Matthias Blüher</name_title>
    <organization>Medical Department, University of Leipzig</organization>
  </responsible_party>
  <keyword>PGC-1alpha</keyword>
  <keyword>PPARgamma</keyword>
  <keyword>oxidative stress</keyword>
  <keyword>training intervention</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

